Wisconsin Administrative Code

PT 5.03 Supervision of students. (1) Except as provided under sub. (2), a physical therapist shall provide direct, immediate, on-premises supervision of a student at all times. (2) (a) A physical therapist providing supervision of a physical therapist assistant student under sub.…

PT 6.001 Authority and purpose. The rules in this chapter are adopted by the board pursuant to the authority delegated by ss. 15.08 (5) (b), 227.11 (2), and 448.56 (1m) (b), Stats., and govern referrals.

PT 6.01 Referrals. (1) In addition to the services excepted from written referral under s. 448.56, Stats., a written referral is not required to provide the following services, related to the work, home, leisure, recreational and educational environments: (a) Conditioning. (b) In…

PT 7.01 Authority and intent. (1) The definitions of this chapter are adopted by the board pursuant to the authority delegated by ss. 15.085 (5) (b) and 448.527, Stats., to establish the standards of ethical conduct by physical therapists and physical therapist assistants. (2) Ph…

PT 7.02 Definitions. For the purposes of these rules: (1) XNegligence in the practice of physical therapyY means an act performed without the care and skill of a reasonable physical therapist or physical therapist assistant who performs the act in question, whether or not the neg…

PT 7.025 Unprofessional conduct. The term Xunprofessional conductY is defined to include violating, aiding, abetting, or conspiring to engage in any of the following: (1) Violating s. 448.57 (2) (a) to (g), Stats., other provision of chs. 440 and 448, Stats., or any provision of …

PT 7.03 Complaints. Procedures and requirements for filing complaints with the board are set forth in ch. SPS 2.

PT 7.04 Self-audits. The board shall biennially review and evaluate its performance in carrying out its responsibilities under this chapter and in other areas over which the board exercises its independent authority, as defined in s. 440.035, Stats. the chapter was last published…

PT 8.01 Authority and purpose. The rules in this chapter are adopted by the board pursuant to the authority delegated by ss. 15.08 (5) (b), 227.11 (2) and 448.53, Stats., and govern biennial renewal of licensees of the board. History: Cr. Register, September, 1995, No. 477, eff. …

PT 8.02 Renewal required; method of renewal. Each licensee shall renew his or her license biennially with the department. Each licensee shall complete a renewal application form and return it with the required fee to the department prior to the next succeeding March 1. History: C…

PT 8.05 Requirements for late renewal and reinstatement. A license shall expire if it is not renewed by March 1 of each odd-numbered year, except for temporary licenses granted pursuant to ch. PT 3. A licensee who allows their license to expire may apply to the board to renew or …

PT 9.01 Authority and purpose. The rules in this chapter are adopted by the board pursuant to the authority delegated by ss. 15.08 (5) (b), 227.11 (2) and 448.55 (3), Stats., and govern required biennial continuing education of licensees of the board.

PT 9.02 Definitions. In this chapter: (1) XContact hourY means not less than 50 minutes a licensee spends in actual attendance at or completion of acceptable continuing education. (2) XContinuing educationY means planned, organized learning activities designed to maintain, improv…

PT 9.03 Continuing education requirements. (1) Unless granted a postponement or waiver under sub. (8), every physical therapist shall complete at least 30 hours of board-approved continuing education in each biennial registration period, as specified in s. 448.55 (3), Stats. Four…

PT 9.04 Standards for approval. (1) To be approved for credit, a continuing education program shall meet all of the following criteria: (a) The program constitutes an organized program of learning that contributes directly to the licensee[s knowledge, skill, behavior, and abiliti…

PT 9.05 Certification and audit of continuing education requirements. Applicants for renewal shall certify completion of required continuing education hours. The board shall audit any licensee who is under investigation by the board for alleged misconduct. the chapter was last pu…

Phar 1.01 Authority. Rules in chs. Phar 1 to 19 are adopted under authority of ss. 15.08 (5) (b) and 227.11 (2), Stats., and ch. 450, Stats. History: Cr. Register, January, 1983, No. 325, eff. 2-1-83; am. Register, August, 1991, No. 428, eff. 9-1-91; am., Register, December, 1998…

Phar 1.02 Definitions. As used in chs. Phar 1 to 19: (1) XBoardY means the pharmacy examining board. Note: The board office is located at 4822 Madison Yards Way, Madison, WI 53705. (2) XCommunity pharmacyY means practice in a licensed pharmacy providing pharmaceutical services pr…

Phar 10.01 Authority. The rules in this chapter are adopted pursuant to the authority in ss. 15.08, 227.11 and 450.02, Stats. History: Cr. Register, January, 1980, No. 289, eff. 2-1-80; renum. from Phar 5.01, Register, January, 1983, No. 325, eff. 2-1-83; correction made under s.…

Phar 10.02 Definitions. In this chapter: (1) “Dispense” has the meaning given in s. 450.01 (7), Stats. (2) “Drug” has the meaning given in s. 450.01 (10), Stats. (3) “Patient” has the meaning given in s. 450.01 (14), Stats. History: Cr. Register, January, 1980, No. 289, eff. 2-1-…

Phar 10.03 Unprofessional conduct. The following, without limitation because of enumeration, are violations of standards of professional conduct and constitute unprofessional conduct in addition to those grounds specified under s. 450.10 (1), Stats.: (1) Administering, dispensing…

Phar 12.01 Authority. The rules in this chapter are adopted under authority in ss. 15.08 (5) (b), 227.11 (2) (a) and 450.07 (4), Stats. History: Cr. Register, August, 1987, No. 380, eff. 9-1-87.

Phar 12.02 Definitions. In this chapter: (1) XDeviceY has the meaning set forth in s. 450.01 (6), Stats. (2) XDrugY has the meaning set forth in s. 450.01 (10), Stats. (3) XEstablishmentY means a place of business under one management at one general physical location. (4) XManufa…

Phar 12.03 License; application. (1) No person may engage in the manufacturing of any drug or device in this state unless a license is granted to the person by the board under this chapter. (2) To obtain a license a person shall do all of the following: (a) Submit an application …

Phar 12.04 Inspections. Before a license is granted, an inspection of the establishment shall be conducted by the board or its representative to determine if the location meets the standards in 21 USC 351 and 352 (2022) and 21 CFR 210 and 211 (2022).

Phar 12.05 Compliance. Failure to comply with all applicable federal and state laws and regulations shall be subject to disciplinary action by the board under s. 450.10, Stats. History: Cr. Register, August, 1987, No. 380, eff. 9-1-87.

Phar 12.06 Authorized distributors of record. A manufacturer shall maintain and update at least once per month a list of the manufacturer[s authorized distributors of record. History: EmR0815: emerg. cr. eff. 6-1-08; CR 08-051: cr. Register November 2008 No. 635, eff. 12-1-08. th…

Phar 13.01 Authority. The rules in this chapter are adopted under authority in ss. 15.08 (5) (b), 227.11 (2) (a), 450.02 (3) (a) and 450.07 (4), Stats. History: Cr. Register, July, 1992, No. 439, eff. 8-1-92.

Phar 13.02 Definitions. In this chapter: (1) XBloodY means whole blood collected from a single donor and processed either for transfusion or further manufacturing. (2) XBlood componentY means that part of blood separated by physical or mechanical means. (3) XControlled substanceY…

Phar 13.05 License; other requirements. In addition to providing the application information, to obtain a license a person shall: (1) Pay the fee specified in s. 440.05 (1), Stats. (2) Pass an inspection of the facility conducted by the board or its representative in the 3-year p…

Phar 13.055 Surety bond, irrevocable letter of credit. The applicant shall supply a surety bond or irrevocable letter of credit in the amount of $5,000.00, which is issued by a company authorized to do business in Wisconsin. The form of the bond or letter of credit shall be appro…

Phar 13.06 License; factors considered. In determining eligibility for a distributor[s license, the board shall consider the following factors: (1) Any convictions of the applicant under any federal, state, or local laws relating to drug samples, wholesale or retail drug or devic…

Phar 13.07 Application review. The board shall act upon an application for a license within 60 business days after receiving the completed application, as provided in s. SPS 4.03. If the license is denied, the applicant may request a hearing pursuant to ch. SPS 1. History: Cr. Re…

Phar 13.08 Personnel. A distributor shall employ adequate personnel with the education and experience necessary to safely and lawfully engage in the wholesale distribution of drugs. History: Cr. Register, July, 1992, No. 439, eff. 8-1-92; EmR0815: emerg. am.

Phar 13.09 Facility requirements. All facilities at which prescription drugs are stored, warehoused, handled, held, offered, marketed, or displayed shall: (1) Be of suitable size and construction to facilitate cleaning, maintenance, and proper operations; (2) Have storage areas d…

Phar 13.10 Security requirements. All facilities shall require that: (1) Access from outside the premises is kept to a minimum and be well controlled; (2) The outside perimeter of the premises is well lighted; (3) Entry into areas where prescription drugs are held is limited to a…

Phar 13.12 Examination of materials requirements. (1) Upon receipt by a facility, each outside shipping container shall be visually examined for identity and to prevent the acceptance of contaminated prescription drugs, or prescription drugs that are otherwise unfit for distribut…

Phar 13.13 Returned, damaged and outdated prescription drug requirements. (1) Prescription drugs in a facility that are outdated, damaged, deteriorated, misbranded, or adulterated shall be quarantined and physically separated from other prescription drugs until they are destroyed…

Phar 13.14 Recordkeeping requirements. (1) A distributor shall establish and maintain inventories and records of all transactions regarding the receipt and distribution or other dispo- Phar 13.16 sition of prescription drugs. These records shall include the following information:…

Phar 13.15 Written policies and procedures. A distributor shall establish, maintain, and adhere to written policies and procedures, which shall be followed for the receipt, security, storage, inventory, and distribution of prescription drugs, including policies and procedures for…

Phar 13.16 Responsible persons. A distributor shall establish and maintain lists of officers, directors, managers, and the chapter was last published. Phar 13.16 WISCONSIN ADMINISTRATIVE CODE the designated representative in charge of wholesale drug distribution, storage, and han…

Phar 13.17 Compliance with federal, state and local laws. (1) A distributor shall operate in compliance with applicable federal, state, and local laws and regulations. A distributor shall operate in compliance with any applicable federal electronic track and trace pedigree system…

Phar 14.01 Application. Each applicant for licensure as a home medical oxygen provider shall submit all of the following: (1) An application for licensure on a form provided by the board. (2) The fee specified in s. 440.05 (1), Stats. (3) Evidence of accreditation by an organizat…

Phar 14.02 Standards of Professional Conduct. Licensed home medical oxygen providers and their employees and agents shall do all of the following: (1) Maintain accreditation status by an organization deemed an accreditation organization for suppliers of durable medical equipment,…

Phar 15.01 Definitions. In this chapter, XUSP-NFY means the United States Pharmacopeia-National Formulary published by the United States Pharmacopeial Convention. Phar 15.02 Incorporation of standards. (1) PHAR- NONSTERILE PREPARATIONS. USP-NF general chapter 795, official as of …

Phar 15.03 Compliance. (1) UNPROFESSIONAL CONDUCT. Noncompliance with ch. Phar 15 shall be considered a violation of s. Phar 10.03 and may result in disciplinary action by the board against a credential holder. (2) DIFFERING REQUIREMENTS. (a) Where any board rule in this chapter …

Phar 16.01 Authority and purpose. The rules in this chapter are adopted by the pharmacy examining board pursuant to the authority delegated by ss. 15.08 (5) (b), 227.11 (2) and 450.02 (2g) (a), Stats. History: Cr. Register, November, 1999, No. 527, eff. 12-1-99.